Rippling muscle disease can be hereditary or immune-mediated, with the latter associated with myasthenia gravis. Muscle rippling without muscle weakness or fatigue has not been well characterized in the literature.
Immune mediated muscle rippling disease (iRMD) with myasthenia gravis (MG) was first reported in the 1990s by Drs. Ansevin and Agamanolis. Since the initial description, more publications have described an association between iRMD and MG with or without thymoma or positive serum acetylcholine receptor (AChR) antibodies. Cases have been published describing alleviation of muscle rippling correlating with remission of myasthenic symptoms with proper immunotherapy. To our knowledge, isolated muscle rippling as the initial and sole manifestation of MG has not previously been reported.